Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Teneligliptin(MP-513) vs. Placebo in Patient With Metformin Monotherapy (T2DM)

This study is currently recruiting participants. (see Contacts and Locations)
Verified March 2013 by Handok Pharmaceuticals Co., Ltd.
Sponsor:
Information provided by (Responsible Party):
Handok Pharmaceuticals Co., Ltd.
ClinicalTrials.gov Identifier:
NCT01805830
First received: December 26, 2012
Last updated: March 5, 2013
Last verified: March 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: August 2013
  Estimated Primary Completion Date: May 2013 (Final data collection date for primary outcome measure)